News and Press Releases
KFSH&RC Announces Strategic Partnership with the Global Health Exhibition
16 October 2023 -- Riyadh, Saudi Arabia -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) plays a critical role in the upcoming Global Health Exhibition 2023, a major event...
Category: Other
Posted: October 16, 2023
Makkah Al Mukarramah Branch Rd, Al Mathar Ash Shamali Saudi Arabia
Antiverse and GlobalBio, Inc extend collaboration to advance antibody cancer therapeutics
Collaboration successfully identified antibodies with therapeutic potential as checkpoint inhibitors in oncology Two antibodies showing high specificity for PD-1 are now being progressed to preclinical development Project leveraged Antiverse’s AI-driven...
Category: Biotechnology
Posted: October 16, 2023
Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster
New free of charge service will offer insights in under ten days to sponsors conducting clinical trials in any indication, identifying potential “zombie trials” and providing actionable recommendations for failing...
Category: Pharmaceutical
Posted: October 12, 2023
Innoviva Specialty Therapeutics Presents New Data on its Critical Care Antibiotic Therapy Portfolio at Infectious Disease Week (IDWeek) 2023
Oral presentation highlights new findings about the efficacy of XACDURO for the treatment of monomicrobial and polymicrobial Acinetobacter baumannii-calcoaceticus infections Researchers share global surveillance data on the in vitro activity of XERAVA (eravacycline) for injection on...
Category: Pharmaceutical
Posted: October 12, 2023
AstraZeneca reinforces commitment to protecting the most vulnerable from serious infectious diseases at IDWeek 2023
Real-world data from INFORM study demonstrate increased risk of severe COVID-19 outcomes among all individuals with immunocompromising conditions and highlight need for additional protection FluMist Quadrivalent data support the potential...
Category: Clinical Trials
Posted: October 12, 2023
PLC 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA UK
Clinical Trials Specialist Panthera Biopartners Scoops Pharma Industry Award
11 October 2023 -- Preston, UK -- After only four years since it was founded, Panthera Biopartners has been crowned ‘Pharma Research Centre of the Year’ at the prestigious Pharma...
Category: Other
Posted: October 11, 2023
Sonrai Analytics Appoints Paul Jones as Chairman of its Board of Directors
Appointment brings extensive expertise to support the Company’s mission of advancing precision medicine through AI. 10 October 2023 – Belfast, Northern Ireland – Sonrai Analytics, a leading AI precision medicine...
Category: Drug Delivery, Drug Discovery
Posted: October 11, 2023
Whitla Medical Building, 97 Lisburn Road, Belfast, BT9 7BL
WCG Raises the Bar in Quality Management Standards, Becoming ISO 9001 Certified in both IRB and IBC
10 October 2023 – Princeton, NJ, US – WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announced today the extension of its ISO 9001 certification...
Category: Clinical Trials, Pharmaceutical
Posted: October 11, 2023
The next generation of SMART Tower Cold Chain containers: ‘easy return’ and custom colours
Tower Cold Chain has announced a series of new initiatives for the KTEvolution, its ‘small box’ solution for direct-to-patient, samples shipment, and last-mile deliveries. Amongst the new offering is a...
Category: Logistics, Manufacturing and Packing
Posted: October 10, 2023
Unit A, Total Park, Station Road, Theale, Reading, Berkshire RG7 4PN, UK
Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer
Key executive leadership role will oversee design and implementation of technology strategy, engineering resources and infrastructure to deliver corporate objectives 10 October 2023 -- London, UK -- Closed Loop Medicine,...
Category: Biotechnology
Posted: October 10, 2023
Babraham Research Campus Cambridge CB22 3AT United Kingdom
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy
EVOLUTION phase 2 trial follows successful phase 1 demonstration of proof of concept for a lung cancer screening test and safety of probe Phase 2 study to focus on assessing...
Category: Clinical Trials
Posted: October 10, 2023
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
Kite’s CAR T-Cell Therapy Accepted for Use on the NHS in Scotland to Treat Aggressive Form of Blood Cancer
First CAR T-cell therapy for adult (26+) patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL) reimbursed in Scotland 9 October 2023 -- London, UK -- Gilead Sciences...
Category: Pharmaceutical
Posted: October 9, 2023
MSD’s WELIREG▼(belzutifan) made available for the treatment of eligible adults with von Hippel-Lindau (VHL) disease in Scotland
Scotland is the first European country to accept belzutifan as a treatment for adult patients with von Hippel-Lindau (VHL) disease who require therapy for VHL-associated renal cell carcinoma (RCC), central...
Category: Pharmaceutical
Posted: October 9, 2023
1 rue Jacques Monod, Site Montesquieu, 33650 Martillac, France
Orakl Oncology raises €3 million to develop its techbio platform forprecision oncology
4 October 2023 -- Paris, France -- Orakl Oncology, a precision oncologystart-up, today announces that it has raised €3m to develop its techbio platform thatintegrates best-in-class biology with real-world patient...
Category: Biotechnology
Posted: October 9, 2023
New Safety Data Suggests SPRAVATO▼ (Esketamine Nasal Spray) is More Tolerable and Effective Compared to Quetiapine Extended-Release (XR) in Adults with Treatment-resistant Major Depressive Disorder
• The new safety data is from the ESCAPE-TRD Phase 3b study• Additional findings from this study showed esketamine NS demonstrated a significant increase in the proportion of patients achieving...
Category: Clinical Trials, Drug Discovery
Posted: October 9, 2023
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
